01 / Our capabilities
Market Intelligence & Evidence
International healthcare companies need to assess demand, clinical practice, purchasing structures and competitive alternatives before committing resources to Mexico. Evidence that supports a product in one country may not answer the questions of Mexican decision-makers.


Market assessment roadmap
An example of how a project can prepare for market entry in Mexico.
Define the market
Narrow down the indication, patient groups, demand and purchasing channels in Mexico.
Potential outputMarket overview and stakeholder map
Assess the evidence
Review clinical data, local comparators and health economic assumptions.
Potential outputOverview of evidence and data gaps
Prioritize opportunities
Compare segments and positioning options by attractiveness, feasibility and uncertainty.
Potential outputPriority segments and positioning hypotheses
Prepare the decision
Bring together assumptions, open questions and next steps for market entry.
Potential outputDecision brief with next steps
The challenge
International healthcare companies need to assess demand, clinical practice, purchasing structures and competitive alternatives before committing resources to Mexico. Evidence that supports a product in one country may not answer the questions of Mexican decision-makers.
How CRMevidence could support
Define the target market and relevant patient groups; map public and private stakeholders; assess epidemiological and market data; review published clinical evidence and health-economic assumptions; identify evidence gaps and prioritise further research.
Potential project outputs
A market landscape, stakeholder map, evidence-gap assessment, positioning hypotheses and a prioritised market-entry decision framework.
Important qualification
Any health technology assessment or economic model must use appropriate data and transparent assumptions. The availability and quality of local evidence require project-specific validation.
Additional detail from CRMevidence corporate profile (November 2026)
The corporate profile identifies market mapping, institutional demand, clinical and economic evidence reviews, comparator selection, budget-impact modelling, procurement monitoring, tender specifications and competitor benchmarking as potential workstreams.
Proposed service scope. Subject to confirmation by CRMevidence.